Osamu Hashimoto
Profile
Performance in office
Tenure
Tenure
Background
He joined the company in 1987 and became Executive Officer and General Manager of Corporate Planning in April 2015. In April 2017 he headed the Health Care Business Sector as Managing Executive Officer, then became Director and Managing Executive Officer in June 2018 and Director and Senior Managing Executive Officer in April 2019. He became President with a background of having led both corporate planning and the health care business.
Selection
In April 2020 he became Representative Director, President and Executive Officer, succeeding Tsutomu Tannowa. He had joined the board in June 2018, one year and ten months before becoming President. In the fiscal year ended March 2020, the year before he took office, consolidated revenue was ¥1,338.9 billion, operating income ¥64.6 billion and net income ¥37.9 billion, with operating income down from ¥93.4 billion the year before.
Initiatives
In the fiscal year ended March 2022, his second year, consolidated revenue was ¥1,612.6 billion and operating income ¥147.3 billion, the highest operating income of his tenure. In FY ended March 2023 revenue grew to ¥1,879.5 billion but operating income fell to ¥129.0 billion, and in FY ended March 2026, the year he stepped down, revenue was ¥1,668.8 billion, operating income ¥73.8 billion and net income ¥34.4 billion. Employees increased from 17,979 in FY ended March 2020 to 19,861 in FY ended March 2024.
Career
Career
Mitsui Chemicals
| Date | Position |
|---|---|
| Apr 1987 | Joined |
| Apr 2015 | Executive Officer, General Manager, Corporate Planning Department |
| Apr 2017 | Managing Executive Officer, General Manager, Healthcare Business Headquarters |
| Jun 2018 | Director, Managing Executive Officer |
| Apr 2019 | Director, Senior Managing Executive Officer |
| Apr 2020 | Representative Director, President, Executive Officer |
| Apr 2026 | Stepped down as President |
References 1
References (Japanese primary sources)
- 三井化学 有価証券報告書（役員の状況）